Bangladesh vs Honduras: Prevalence rate of hypertension in women aged 30-79
Bangladesh
34.2
in 2019
Honduras
34.4
in 2019
Bangladesh rank
131st
Honduras rank
129th
Prevalence rate of hypertension in women aged 30-79 over time
- Bangladesh
- Honduras
How they compare
Honduras currently reports 34.4 against 34.2 in Bangladesh, a difference of 0.2.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Bangladesh ahead.
Bangladesh ranks 131st and Honduras ranks 129th of 195 countries.
Across the 3 decades both report, Bangladesh averaged higher in 1 and Honduras in 2.
Head to head by decade
| Decade | Bangladesh | Honduras | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 31.93 | 31.44 | 0.49 | Bangladesh |
| 2000s | 31.77 | 33.14 | 1.37 | Honduras |
| 2010s | 32.65 | 34.37 | 1.72 | Honduras |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in women aged 30-79, Bangladesh or Honduras?
- Honduras, at 34.4 against 34.2 in Bangladesh as of 2019.
- What is the difference in prevalence rate of hypertension in women aged 30-79 between Bangladesh and Honduras?
- 0.2, with Honduras ahead.
- How many years of comparable data are there for Bangladesh and Honduras?
- 30 years are reported by both, from 1990 to 2019.
- How do Bangladesh and Honduras rank globally for prevalence rate of hypertension in women aged 30-79?
- Bangladesh ranks 131st and Honduras ranks 129th of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in women aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of female population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.